Skip to content

Clinical trials

Growth Disorders trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Growth Disorders Country / region: Singapore Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Danone Asia Pacific Holdings Pte, Ltd.2
Merck KGaA, Darmstadt, Germany1
QED Therapeutics, a BridgeBio company1
University of Southampton1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Growth Disorders5
Achondroplasia1
Bone Diseases1
Communicable Diseases1
Dermatitis, Atopic1
Dwarfism1
Hypersensitivity1
Mucopolysaccharidosis IV1
Musculoskeletal Diseases1
Neurobehavioral Manifestations1

Trials

Showing 76 to 5 of 5. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.